awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q48109284-2E2D01D2-3880-4A57-8D13-5A59861169EA
Q48109284-2E2D01D2-3880-4A57-8D13-5A59861169EA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48109284-2E2D01D2-3880-4A57-8D13-5A59861169EA
JAK inhibitors for the treatment of myeloproliferative neoplasms and other disorders.
P2860
Q48109284-2E2D01D2-3880-4A57-8D13-5A59861169EA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48109284-2E2D01D2-3880-4A57-8D13-5A59861169EA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1b7cb61de7553ee9966e59118dcc24aa74c3c217
P2860
Ruxolitinib vs best available therapy for ET intolerant or resistant to hydroxycarbamide.